OrganiGram Holdings (OGI) has notable insider buying

OrganiGram Holdings (T:OGI)

Peter Amirault, a Director, acquired 20,000 Common Shares on a direct ownership basis at a price of $3.390 through a prospectus or prospectus exempt offering on December 18th, 2017. This represents a $67,800 investment into the company's shares and an account share holdings change of 20.0%.

Gregory Malcolm Engel, CEO and Director, acquired 50,000 Common Shares on a direct ownership basis at a price of $3.390 through a prospectus or prospectus exempt offering on December 18th, 2017. This represents a $169,500 investment into the company's shares and an account share holdings change of greater than 100%.

Michael David Tripp, a Senior Officer, acquired 28,572 Common Shares on a direct ownership basis at a price of $3.390 through a prospectus or prospectus exempt offering on December 18th, 2017. This represents a $96,859 investment into the company's shares and an account share holdings change of 50.8%.

OrganiGram Holdings Inc., formerly Inform Exploration Corp., is a Canada-based company, which operates through its subsidiary Organigram Inc. Organigram Inc. is a licensed medical marijuana producer as regulated by Health Canada under the Marihuana Medical Access Regulations (MMAR) of the Government of Canada.